Cibc Asset Management Inc Novo Nordisk A S Transaction History

Cibc Asset Management Inc

  • $29.6 Billion
  • Q2 2025

A detailed history of Cibc Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cibc Asset Management Inc holds 89,883 shares of NVO stock, worth $4.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
89,883
Previous 72,424 24.11%
Holding current value
$4.92 Million
Previous $5.03 Million 23.34%
% of portfolio
0.02%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$58.08 - $81.05 $1.01 Million - $1.42 Million
17,459 Added 24.11%
89,883 $6.2 Million
Q1 2025

May 13, 2025
SELL
$69.3 - $90.95 $77,823 - $102,136
-1,123 Reduced 1.53%
72,424 $5.03 Million
Q4 2024

Jan 31, 2025
BUY
$85.0 - $120.04 $339,065 - $478,839
3,989 Added 5.73%
73,547 $6.33 Million
Q3 2024

Nov 06, 2024
BUY
$119.07 - $145.42 $296,960 - $362,677
2,494 Added 3.72%
69,558 $8.28 Million
Q2 2024

Aug 01, 2024
SELL
$122.71 - $146.91 $371,688 - $444,990
-3,029 Reduced 4.32%
67,064 $9.57 Million
Q1 2024

May 09, 2024
SELL
$102.11 - $135.92 $27,569 - $36,698
-270 Reduced 0.38%
70,093 $9 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $25,982 - $31,213
-296 Reduced 0.42%
70,363 $7.28 Million
Q3 2023

Oct 30, 2023
BUY
$90.94 - $199.54 $3.22 Million - $7.06 Million
35,400 Added 100.4%
70,659 $6.43 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $1.52 Million - $1.69 Million
9,773 Added 38.35%
35,259 $5.71 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $184,349 - $221,682
-1,393 Reduced 5.18%
25,486 $4.06 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $223,969 - $295,560
-2,184 Reduced 7.51%
26,879 $3.64 Million
Q3 2022

Nov 03, 2022
BUY
$95.28 - $116.93 $20,580 - $25,256
216 Added 0.75%
29,063 $2.9 Million
Q2 2022

Aug 09, 2022
SELL
$103.24 - $121.81 $527,866 - $622,814
-5,113 Reduced 15.06%
28,847 $3.21 Million
Q1 2022

May 06, 2022
BUY
$93.1 - $112.54 $2.91 Million - $3.52 Million
31,239 Added 1148.07%
33,960 $3.77 Million
Q4 2021

Feb 08, 2022
BUY
$95.88 - $117.08 $17,450 - $21,308
182 Added 7.17%
2,721 $305,000
Q3 2021

Nov 09, 2021
SELL
$84.42 - $106.62 $35,709 - $45,100
-423 Reduced 14.28%
2,539 $244,000
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $1.98 Million - $2.48 Million
-29,300 Reduced 90.82%
2,962 $248,000
Q1 2021

May 14, 2021
BUY
$67.06 - $75.82 $1,676 - $1,895
25 Added 0.08%
32,262 $2.18 Million
Q4 2020

Feb 03, 2021
SELL
$63.89 - $73.8 $2.33 Million - $2.69 Million
-36,435 Reduced 53.06%
32,237 $2.25 Million
Q3 2020

Nov 05, 2020
SELL
$63.69 - $70.22 $148,079 - $163,261
-2,325 Reduced 3.27%
68,672 $4.77 Million
Q2 2020

Jul 28, 2020
SELL
$58.54 - $67.94 $52,978 - $61,485
-905 Reduced 1.26%
70,997 $4.65 Million
Q1 2020

Apr 30, 2020
SELL
$49.46 - $64.78 $647,431 - $847,970
-13,090 Reduced 15.4%
71,902 $4.33 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $127,043 - $148,446
-2,548 Reduced 2.91%
84,992 $4.92 Million
Q3 2019

Oct 30, 2019
SELL
$47.54 - $53.43 $123,604 - $138,918
-2,600 Reduced 2.88%
87,540 $4.53 Million
Q2 2019

Aug 05, 2019
SELL
$46.79 - $52.47 $8.41 Million - $9.43 Million
-179,799 Reduced 66.61%
90,140 $4.6 Million
Q1 2019

May 06, 2019
BUY
$46.36 - $52.63 $1.02 Million - $1.16 Million
22,108 Added 8.92%
269,939 $14.1 Million
Q4 2018

Feb 12, 2019
BUY
$41.54 - $47.25 $10.3 Million - $11.7 Million
247,831 New
247,831 $11.4 Million

Others Institutions Holding NVO

# of Institutions
1,710
Shares Held
312M
Call Options Held
13.7M
Put Options Held
19.7M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $124B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cibc Asset Management Inc Portfolio

Follow Cibc Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email